Accessibility Menu
MustGrow Biologics logo

MustGrow Biologics(TSXV) MGRO

Market CapCA$28.65MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2019)+42%
5 Year-84%
1 Year-39%
1 Month+42%
CA$0.46
-4.21%
-0.02Today
MustGrow Biologics last closing stock price
MetricPriceDate
Last closeCAD 0.462026-08-31
MustGrow Biologics stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+1.11%CAD 0.452026-08-24
1 month+42.19%CAD 0.322026-07-31
3 month-7.14%CAD 0.492026-06-02
Year to date-27.78%CAD 0.632025-12-31
1 year-39.33%CAD 0.752025-08-29
3 year-69.67%CAD 1.502023-09-01
5 year-83.75%CAD 2.802021-09-01
Since inception+42.19%CAD 0.322019-07-10

MustGrow Biologics Financials at a Glance

Market Cap

CA$28.65MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$3.19M

Net Income (TTM)

-CA$5.57M

EPS (TTM)

-CA$0.10

P/E Ratio

-4.69

Dividend

CA$0.00

Beta (Volatility)

0.13 (Low)

Price

CA$0.46

Volume

11,000

Open

CA$0.47

Previous Close

CA$0.46

Daily Range

CA$0.45 - CA$0.47

52-Week Range

CA$0.29 - CA$0.94

Estimated Earnings Date

Sep 2, 2026

MGRO News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About MustGrow Biologics

MustGrow Biologics Corp. is an agricultural biotechnology company focused on developing and commercializing natural crop protection solutions derived from mustard seed. The company specializes in biopesticides, biofumigants, and bioherbicides, aiming to enhance agricultural productivity while promoting sustainable farming practices.

Products and Services
  • Biopesticides for effective pest management
  • Biofumigants to combat soil-borne diseases
  • Bioherbicides for organic farming and home gardens
Growth Outlook
  • Expanding market for sustainable agricultural solutions
  • Increased demand for organic farming practices
  • Ongoing development of innovative products like CannaPM
Financial Highlights
  • Recent quarterly revenue of CAD 98,182, showing growth potential
  • Trailing twelve months (TTM) revenue of CAD 4,708,853, indicating market interest
  • Current ratio of 1.88, suggesting strong short-term financial health
MustGrow Biologics Corp. operates in the agricultural inputs sector, providing innovative solutions that align with the growing trend towards sustainable farming. The company's focus on natural products positions it well in a market increasingly concerned with environmental impact. Recent financial data indicates a revenue increase, reflecting the company's potential for growth. The current ratio suggests that MustGrow is well-equipped to meet its short-term obligations, which is a positive indicator for potential investors. The ongoing development of products like CannaPM further enhances the company's prospects in the agricultural biotechnology space.
AI Generated • Aug 8, 2026

Industry

Chemicals

Sector

Materials

Employees

8

CEO

Corey J. Giasson, MBA

Website

www.mustgrow.ca

Headquarters

Saskatoon, SK S7K 1J5, CA

MGRO Financials

Key Financial Metrics (TTM)

Gross Margin

52.78%

Operating Margin

-132.57%

Net Income Margin

-174.40%

Return on Equity

-218.75%

Return on Capital

-430.85%

Return on Assets

-77.72%

Earnings Yield

-21.32%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

CA$28.65MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

62.96M

Volume

11.00K

Avg. Volume

46.14K

Financials (TTM)

Gross Profit

CA$1.68M

Operating Income

-CA$4.23M

EBITDA

-CA$4.20M

Operating Cash Flow

-CA$2.85M

Capital Expenditure

-CA$1.49M

Free Cash Flow

-CA$4.34M

Cash & ST Invst.

CA$4.37M

Total Debt

CA$515.57K

MustGrow Biologics Performance Analysis

MustGrow Biologics annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CAD 6,479-49.7%
20232023-12-31CAD 4,712,20072630.4%
20242024-12-31CAD 398,018-91.6%
20252025-12-31CAD 8,286,5411982.0%
MustGrow Biologics sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-72.3%
Q42025-12-319.8%
Q12026-03-31-88.7%
Q22026-06-301364.8%
MustGrow Biologics annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CAD -0.1162.3%
20232023-12-31CAD -0.01-88.0%
20242024-12-31CAD -0.09597.1%
20252025-12-31CAD -0.1340.8%
MustGrow Biologics sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-112.4%
Q42025-12-3119.6%
Q12026-03-3140.1%
Q22026-06-30121.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CA$1.44M

-49.5%

Gross Profit

CA$1.36M

+129.0%

Gross Margin

94.68%

N/A

Market Cap

CA$28.65MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

CA$3.58M

N/A

Employees

8

N/A

Net Income

CA$284.70K

+126.1%

EBITDA

CA$429.86K

+142.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CA$4.37M

+140.2%

Total Debt

CA$515.57K

-83.6%

Accounts Receivable

CA$1.44M

+60.1%

Inventory

CA$566.83K

-69.2%

Long Term Debt

CA$138.51K

-94.7%

Short Term Debt

CA$377.06K

-29.1%

Return on Assets

-77.72%

N/A

Return on Invested Capital

-81.56%

N/A

Free Cash Flow

CA$613.26K

+281.5%

Operating Cash Flow

CA$613.26K

+287.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MRZ.VMirasol Resources Ltd.
CA$0.34-1.47%
NPR.VNorth Peak Resources Ltd.
CA$0.74-1.33%
SAM.TOStarcore International Mines Ltd.
CA$0.49-3.00%
AAN.VAton Resources Inc.
CA$0.52+4.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About MGRO

What is the current price of MustGrow Biologics?

MustGrow Biologics is trading at CA$0.46 per share.

What is the 52-week range for MustGrow Biologics?

Over the past 52 weeks, MustGrow Biologics has traded between CA$0.29 and CA$0.94.

How much debt does MustGrow Biologics have?

As of the most recent reporting period, MustGrow Biologics reported total debt of CA$515.57K.

How much cash does MustGrow Biologics have on hand?

MustGrow Biologics reported CA$4.37M in cash and cash equivalents in its most recent financial results.

What is MustGrow Biologics’s dividend yield?

MustGrow Biologics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services